Atea Pharmaceuticals Inc. – State Reviewer

Markets

Is Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Still Worth A Bite?

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Relative Strength Index (RSI) is 44.96, with weekly volatility at 9.51% and ATR at 1.91. The AVIR stock’s 52-week price range

Finance

AVIR Stock: Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Is Still Worth a Bite

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares traded lower over the last trading session, losing -0.97% on 06/15/21. The shares fell to a low of $22.74 before

Companies

Atea Pharmaceuticals Inc. (NASDAQ:AVIR): A Stocks With Stellar Fundamentals?

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) has a 12-month trailing P/E ratio of 92.92. The stock’s Relative Strength Index (RSI) is 44.35, with weekly volatility at 7.56%

Companies

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) slip over -8.96% in a week: Is AVIR Giving A Buy Signal?

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares traded lower over the last trading session, losing -0.63% on 05/28/21. The shares fell to a low of $20.20 before

Industry

Are Investors Unfairly Punishing Atea Pharmaceuticals Inc. (NASDAQ:AVIR)?

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) shares fell to a low of $19.47 before closing at $19.52. Intraday shares traded counted 0.77 million, which was -8.23% lower

Tag: Atea Pharmaceuticals Inc.

Is Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Still Worth A Bite?

AVIR Stock: Atea Pharmaceuticals Inc. (NASDAQ:AVIR) Is Still Worth a Bite

Atea Pharmaceuticals Inc. (NASDAQ:AVIR): A Stocks With Stellar Fundamentals?

Atea Pharmaceuticals Inc. (NASDAQ:AVIR) slip over -8.96% in a week: Is AVIR Giving A Buy Signal?

Are Investors Unfairly Punishing Atea Pharmaceuticals Inc. (NASDAQ:AVIR)?

Quick Links

Categories